UK Markets closed
NIKKEI 225
27,433.40 +50.84 (+0.19%) HANG SENG
22,069.73 -619.17 (-2.73%) CRUDE OIL
77.81 -1.87 (-2.35%) GOLD FUTURES
1,939.00 -0.20 (-0.01%) DOW
33,717.09 -260.99 (-0.77%) BTC-GBP
18,413.57 -921.97 (-4.77%)
Calliditas Therapeutics AB (publ) (0A5R.L)
LSE - LSE Delayed price. Currency in SEK
Add to watchlist
At close: 05:55PM GMT
| Previous close | 99.86 |
| Open | 98.90 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 98.20 - 99.60 |
| 52-week range | 98.20 - 99.60 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -9.66 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
New Strong Sell Stocks for January 6th
CALT, CVGW and DFH have been added to the Zacks Rank #5 (Strong Sell) List on January 6, 2023.
- Zacks
Aurinia (AUPH) Moves 13.1% Higher: Will This Strength Last?
Aurinia (AUPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Zacks
Can Calliditas Therapeutics AB Sponsored ADR (CALT) Climb 160% to Reach the Level Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 160.3% in Calliditas Therapeutics AB Sponsored ADR (CALT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
© 2023 Yahoo. All rights reserved.
